Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib Maintenance in Newly Diagnosed Advanced Ovarian Cancer (POLO)
NCT05187208Phase 4Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of niraparib in ovarian cancer, sponsored by Seoul National University Hospital. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05187208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05187208.